Outsized Ventures

Emitwise Ltd is a London-based company that specializes in software solutions for carbon footprint management. Founded in 2019, Emitwise offers a unique AI-driven platform that enables businesses to automatically measure, report, and reduce their carbon emissions across their operations and supply chains. By providing real-time insights, Emitwise equips companies with the necessary tools to effectively address the climate emergency and transition towards a net-zero carbon future. The company is supported by prominent Silicon Valley investors and has gained the trust of leading global businesses, positioning itself as a critical partner in the effort to combat climate change.

Treos Bio is a clinical-stage biotechnology company focused on developing precision cancer immunotherapies tailored to the genetic profiles of patients. Founded in 2013 and based in San Francisco, the company utilizes proprietary technology to predict individual responses to cancer immunotherapies. Treos Bio offers several products, including PEPI, a test that analyzes genetic data from blood or saliva samples to forecast an individual's immune response to specific antigens. The company also develops PolyPEPI immunotherapy vaccines targeting various cancers such as melanoma, lung cancer, and breast cancer, alongside the PolyPEPI CDx companion diagnostic test, which assesses the effectiveness of treatments for individual patients. Additionally, Treos Bio provides a melanoma screening test to identify individuals at high risk of developing the disease based on genetic information. Through the integration of computational data science and proprietary biomarkers, Treos Bio aims to personalize cancer treatment with targeted vaccines and diagnostic tools.

Living Optics Limited is a company based in Oxford, United Kingdom, that specializes in the design and development of advanced imaging technology. Established in 2019, the company focuses on a compact hyperspectral camera system that utilizes innovative hardware design and software processing. This technology captures data beyond the capabilities of the human eye and conventional cameras, making hyperspectral imaging more accessible and affordable. Living Optics' products cater to a diverse array of applications, including consumer products, medical devices, and various industrial sectors. The company primarily serves computer vision developers and scientists, enabling them to integrate spectral imaging data into new applications and research initiatives.

Magdrive Limited develops a next generation of spacecraft propulsion for small satellites. The company offers technology of new plasma thruster that combines both high thrust of chemical rockets and the high efficiency of other electric thrusters. The company was incorporated in 2019 and is based in Didcot, United Kingdom.

Hoxton Farms, located in London, UK, specializes in producing real animal fat without the use of animals. The company employs a unique combination of cell biology and mathematical modeling to create cultivated fat, specifically designed as an ingredient for the meat alternatives industry. By utilizing a tissue culture system in bioreactors, Hoxton Farms offers purified animal fat that serves various sectors, including meat, bakery, confectionery, and cosmetics, thus providing a cruelty-free option for manufacturers seeking sustainable ingredients.

Kernal Biologics, Inc. specializes in the design and development of mRNA immunotherapies aimed at treating diseases such as COVID-19 and various cancers. Founded in 2016 and headquartered in Cambridge, Massachusetts, the company utilizes its mRNA platform to assist researchers and organizations in creating vaccines and therapeutics. Kernal's innovative therapies instruct specific cells to produce their own therapeutic agents, thereby enhancing treatment efficacy. The company has garnered recognition for its work, receiving multiple awards from notable institutions, including Amgen and NASA. With a foundation rooted in research from MIT and Harvard, the team at Kernal Biologics possesses extensive expertise in the mRNA field, building on their prior successes in the biotechnology sector.

Biomage focuses on single-cell analysis to advance life sciences by providing innovative computational methods to derive insights from biological data. The company has developed the Biomage Single Cell Platform, which allows researchers to efficiently analyze single-cell RNA sequencing data. This platform transforms complex datasets into actionable biological insights, facilitating research in both academia and industry. By streamlining the data analysis process, Biomage empowers scientists to enhance drug target discovery while making the application of advanced sequencing technologies more accessible and cost-effective.

Phenomic AI is a developer of a drug discovery platform designed to discovery and optimize therapeutics directly against phenotypic assays.The company's platform uses artificial intelligence to analyze phenotypes in complex disease models including high-content co-culture and 3D assays, enabling pharmaceutical companies to discover drugs in an easier way.

Mahana Therapeutics, Inc. develops an application for treating patients suffering from gastrointestinal (GI) diseases and conditions. The company offers Parallel, a clinically-validated and minimal-contact digital program for people with irritable bowel syndrome (IBS). Mahana Therapeutics, Inc. was formerly known as Mahana Health, Inc. and changed its name to Mahana Therapeutics, Inc. in July 2019. The company was incorporated in 2018 and is based in San Francisco, California. It has an additional location in London, United Kingdom.

Temporall is a developer of a workplace intelligence platform that leverages artificial intelligence and analytics to enhance organizational effectiveness. The platform integrates and analyzes fragmented data from various sources within a company, providing leadership teams with critical performance insights. By employing machine learning techniques, Temporall enables organizations to receive expert recommendations and detailed reporting, ultimately guiding clients in optimizing their performance. The company's focus is on merging advanced technology with human expertise to address the strategic needs of its clients.